
Atharv Enterprises Q1 Results FY27: Net Profit Rises 7.33% to Rs 0.05 Cr
Atharv Enterprises Q1 FY27: PAT Rs 0.05 Cr (+7.33% YoY), revenue Rs 0.11 Cr (-58.65%). Stock rose 0.28% to Rs 3.61 on 22 July 2026.
Updated: 23 Jul 2026 • 9:31 am
Posted by:

Atharv Enterprises Q1 results FY27 are out. The company reported a standalone net profit of Rs 0.05 Cr for the quarter ended 30 June 2026, up 7.33% from Rs 0.05 Cr in the year ago quarter, in results announced on Wednesday, 22 July 2026.
Shares of Atharv Enterprises rose 0.28% to Rs 3.61 on the results day. The company is a small BSE listed enterprises company.
Click Here – Get Free Investment Predictions
Atharv Enterprises Q1 Results FY27 Key Takeaways
Here are the most important numbers from the June 2026 quarter at a glance.
- Net Profit (PAT): Rs 0.05 Cr in Q1 FY27 versus Rs 0.05 Cr in Q1 FY26, a change of +7.33% year on year.
- Revenue: Rs 0.11 Cr in Q1 FY27 versus Rs 0.26 Cr in Q1 FY26, a change of -58.65%.
- Gross Profit: Rs -0.76 Cr in Q1 FY27 versus Rs -0.70 Cr in Q1 FY26, a change of -8.69%.
- Results announced on Wednesday, 22 July 2026 for the quarter ended 30 June 2026 on a standalone basis.
- Atharv Enterprises share price rose 0.28% to Rs 3.61 on the results day.
Atharv Enterprises Q1 Results FY27 Financial Highlights
The table below summarises the standalone numbers reported in the Atharv Enterprises Q1 results FY27 against the year ago quarter.
| Metric | Q1 FY27 | Q1 FY26 | YoY Change |
|---|---|---|---|
| Revenue | Rs 0.11 Cr | Rs 0.26 Cr | -58.65% |
| Gross Profit | Rs -0.76 Cr | Rs -0.70 Cr | -8.69% |
| Net Profit (PAT) | Rs 0.05 Cr | Rs 0.05 Cr | +7.33% |
All figures are on a standalone basis as reported for the quarter ended 30 June 2026.
Atharv Enterprises Q1 Results FY27 Performance Analysis
Get Personalised Guidance from a SEBI-Registered Investment Advisor
Profit growth is the headline of the Atharv Enterprises Q1 results FY27. Revenue declined 58.65% to Rs 0.11 Cr from Rs 0.26 Cr. Gross profit fell 8.69% to Rs -0.76 Cr from Rs -0.70 Cr.
The divergence between the revenue line and gross profit in the Atharv Enterprises Q1 results FY27 points to cost pressure at the operating level, with the bottom line supported by items below the operating line.
Atharv Enterprises Q1 Results FY27: Key Business Factors
1. Topline Pressure
Revenue declined 58.65% to Rs 0.11 Cr from Rs 0.26 Cr. This sets the base against which the rest of the P&L in the Atharv Enterprises Q1 results FY27 should be read.
2. Margin Pressure
Gross profit fell 8.69% to Rs -0.76 Cr from Rs -0.70 Cr. The gross profit trend is the cleanest read on operating health in the quarter.
3. Bottom Line Delivery
The net result of Rs 0.05 Cr captures the combined effect of operations, other income, finance costs and tax for the quarter.
Dividend Details
Any dividend announcement accompanying the June 2026 quarter results will be reflected in the company’s official NSE and BSE filings. Investors should rely on those filings for dividend confirmation rather than secondary sources.
Atharv Enterprises Q1 Results FY27 Outlook for the Full Year
The Atharv Enterprises Q1 results FY27 set the tone for FY27. The next markers are the September quarter numbers, any guidance from management, and how costs and demand evolve through the festive half of the year.
Atharv Enterprises Stock Performance After the Q1 Results
Download the Univest iOS App or Univest Android App to track Atharv Enterprises live share price and upcoming quarterly results.
Atharv Enterprises share price rose 0.28% to Rs 3.61 on the results day, as the market weighed the quarter’s numbers against expectations.
Investors can compare the trend of the counter with the Nifty 500 index to judge how the stock is placed relative to the broader market after the June quarter results.
Key Risks
Investors going through the fine print of the Atharv Enterprises Q1 results FY27 should also weigh the following risks.
1. Sustaining the Growth Rate
The growth reported in the Atharv Enterprises Q1 results FY27 sets a higher base for coming quarters, and any moderation could disappoint a market that extrapolates.
2. Margin Durability
Whether the quarter’s operating performance holds depends on input costs, pricing power and mix, all of which can shift quickly.
3. Execution and External Risks
Demand cycles, regulatory changes and sector specific shocks remain outside management control and can reset expectations.
Conclusion
Atharv Enterprises Q1 results FY27 show standalone net profit of Rs 0.05 Cr for the quarter ended 30 June 2026, up 7.33% from Rs 0.05 Cr in the year ago quarter. Revenue declined 58.65% to Rs 0.11 Cr from Rs 0.26 Cr. The September quarter will show whether this quarter’s trend extends. Investors should verify the filings on NSE and BSE and consult a SEBI-registered advisor before acting on the numbers.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Atharv Enterprises Q1 Results FY27
When were the Atharv Enterprises Q1 results FY27 announced?
Ans. The Atharv Enterprises Q1 results FY27 were announced on Wednesday, 22 July 2026, for the quarter ended 30 June 2026, on a standalone basis.
What is the PAT in the Atharv Enterprises Q1 results FY27?
Ans. The standalone PAT in the Atharv Enterprises Q1 results FY27 stood at Rs 0.05 Cr, a change of +7.33% from Rs 0.05 Cr in Q1 FY26.
What was the revenue in the Atharv Enterprises Q1 results FY27?
Ans. The revenue in the Atharv Enterprises Q1 results FY27 stood at Rs 0.11 Cr, a change of -58.65% from Rs 0.26 Cr in Q1 FY26.
What was the gross profit in the Atharv Enterprises Q1 results FY27?
Ans. Gross profit for the June 2026 quarter stood at Rs -0.76 Cr, compared with Rs -0.70 Cr in Q1 FY26, a change of -8.69% year on year.
Are the Atharv Enterprises Q1 results FY27 standalone or consolidated?
Ans. The figures discussed here are on a standalone basis, as reported for the quarter ended 30 June 2026.
How did the share price react after the Atharv Enterprises Q1 results FY27?
Ans. Atharv Enterprises share price rose 0.28% to Rs 3.61 on the results day.
Is the stock a good buy after the Atharv Enterprises Q1 results FY27?
Ans. The Atharv Enterprises Q1 results FY27 are one input among many. Valuation, sector conditions and risk appetite matter as much as a single quarter. This article is for educational purposes only. Consult a SEBI-registered advisor before investing.
Where can I verify the Atharv Enterprises Q1 results FY27?
Ans. The official filings for the Atharv Enterprises Q1 results FY27 are available on the NSE and BSE websites, and the stock can be tracked on the Univest app.
Recent Articles

JB Chemicals vs Indoco Remedies Business Model: Which Domestic Branded Formulations Wins
23 July 2026

Alembic vs Ipca Laboratories Business Model: Which Domestic Branded Formulations Wins
23 July 2026

Glenmark Pharmaceuticals vs JB Chemicals Business Model: Which Domestic Branded Formulations Wins
23 July 2026

ABSL Government Securities Direct Growth: NAV Today, Performance Review and Should You Invest?
23 July 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
JB Chemicals vs Indoco Remedies Business Model: Which Domestic Branded Formulations Wins
Alembic vs Ipca Laboratories Business Model: Which Domestic Branded Formulations Wins
Glenmark Pharmaceuticals vs JB Chemicals Business Model: Which Domestic Branded Formulations Wins
ABSL Government Securities Direct Growth: NAV Today, Performance Review and Should You Invest?
Ipca Laboratories vs Mankind Pharma Business Model: Which Domestic Branded Formulations Wins
Popular this week
JB Chemicals vs Indoco Remedies Business Model: Which Domestic Branded Formulations Wins
Alembic vs Ipca Laboratories Business Model: Which Domestic Branded Formulations Wins
Glenmark Pharmaceuticals vs JB Chemicals Business Model: Which Domestic Branded Formulations Wins
ABSL Government Securities Direct Growth: NAV Today, Performance Review and Should You Invest?
Ipca Laboratories vs Mankind Pharma Business Model: Which Domestic Branded Formulations Wins

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





